Previous 10 | Next 10 |
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Becton, Dickinson ( NYSE: BDX ) announced on Thursday that its BD MAX Respiratory Viral Panel (RVP) — a combination test designed to detect multiple respiratory infections including COVID-19 — has been CE marked in the in Europe under the In Vitro Diagnostics Dir...
BD Launches Combination Test for COVID-19, Influenza A/B and Respiratory Syncytial Virus PR Newswire BD MAX™ Molecular Diagnostic Respiratory Viral Panel CE Marked to IVD Directive FRANKLIN LAKES, N.J. , June 30, 2022 /PRNewswire/ ...
Becton, Dickinson has been underperforming since a massive $24 billion deal for Bard in 2017. Leverage and earnings multiples have gradually compressed, but lackluster operating performance prevents me from getting too upbeat. Right now, I find myself in a neutral position at best...
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend Champion, Contender, An...
The shares of Becton, Dickinson (NYSE:BDX) are trading higher in the pre-market Friday on low volume after Wells Fargo upgraded the health equipment maker to Overweight from Equal Weight, calling the stock “one of the best defensive names in MedTech.” The analyst Larry Biegelsen...
Becton, Dickinson and Company (NYSE:BDX) on Wednesday said it was voluntarily recalling some of its intraosseous products due to some issues. The products being recalled are certain lots of the BD Intraosseous Needle Set Kits, BD Intraosseous Manual Driver Kits and BD Intraosseous Powered Dri...
BD Announces Voluntary Recall on Intraosseous Products PR Newswire FRANKLIN LAKES, N.J. , June 22, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company), a leading global medical technology company, announced a voluntary recall on the BD™ In...
Eastern Health and BD Implement Innovative Solution with Goal of Reducing Consumption of Antibiotics and Other Medications Canada NewsWire A first in Canada , implementing the BD HealthSight™ combines timely surveillance to support the early detection of emerg...
Becton, Dickinson (NYSE:BDX -1.8%) said on Monday it was collaborating with Mayo Clinic Platform to access patient data to perform post-market surveillance on its products. (BDX) will get access to de-identified data sets available from 10 million patients, including both structured and ...
News, Short Squeeze, Breakout and More Instantly...
Becton Dickinson and Company Company Name:
BDX Stock Symbol:
NYSE Market:
Becton Dickinson and Company Website:
2024-08-02 11:15:08 ET Raymond James analyst issues OUTPERFORM recommendation for BDX on August 2, 2024 09:49AM ET. The previous analyst recommendation was Outperform. BDX was trading at $239.0875 at issue of the analyst recommendation. The overall analyst consensus : BU...
2024-08-02 10:10:00 ET August 2, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Tech, Automotive, Biotech and Retail Sectors. The newest automotive stocks are involved in r...
2024-08-02 09:00:11 ET Larry Biegelsen from Wells Fargo issued a price target of $280.00 for BDX on 2024-08-02 08:16:00. The adjusted price target was set to $280.00. At the time of the announcement, BDX was trading at $236.01. The overall price target consensus is at $2...